U.S. Health Care REITs Stock News

DENTSPLY SIRONA reported a US$263 million noncash impairment charge related to goodwill and intangible assets for the third quarter of 2025, revised its full-year sales guidance downward, and announced the departure of its Chief Financial Officer. The impairment was primarily attributed to tariffs and reduced projected equipment, implant, and prosthetic volumes in the U.S., signaling potential challenges in some of the company’s core markets. We’ll examine how the impairment charge and...

F&G Annuities & Life announced a 14% increase in its quarterly common dividend to US$0.25 per share, alongside reporting robust third-quarter earnings with revenue reaching US$1.69 billion and net income of US$118 million, a turnaround from a net loss a year ago. This combination of a higher dividend and improved profitability highlights management's confidence in the company's cash flow and ongoing business momentum. We'll explore how the increased dividend signals sustained earnings...

Bumble Inc. recently reported third-quarter 2025 results showing improved profitability, despite sales falling to US$246.16 million from US$273.61 million in the prior year, and provided fourth-quarter revenue guidance in the US$216 million to US$224 million range. An additional shelf registration for US$127.2 million in Class A Common Stock was filed, connected to an employee stock ownership plan offering, underscoring Bumble's focus on employee incentives. We’ll assess how Bumble’s return...

Wondering if Photronics is underestimated or overpriced right now? You are not alone; many investors are taking a closer look at where true value might lie in this stock. Despite a dip of 2.7% over the past week and a 10.1% slide in the last month, Photronics still boasts an impressive 90.3% return over the last five years, which may hint at strong long-term potential. Recent news around advancements in semiconductor manufacturing processes and broader industry consolidation is sparking...

LegalZoom.com, Inc. recently raised its full-year 2025 revenue guidance to a range of US$748 million to US$752 million and reported third-quarter sales of US$190.16 million, alongside an update on its ongoing share repurchase program. While the company saw robust sales growth, its net income declined year-over-year, highlighting both current operational momentum and ongoing profitability challenges. We'll explore how LegalZoom's upgraded revenue guidance shapes the company's future outlook...

Earlier this month, Viridian Therapeutics announced the successful submission of a Biologics License Application (BLA) to the U.S. FDA for veligrotug, its investigational monoclonal antibody for thyroid eye disease, backed by data from two pivotal phase 3 trials. This milestone marks a significant regulatory step with the potential to offer a new therapy option for patients affected by thyroid eye disease, supported by evidence of efficacy and safety. We’ll explore how the BLA submission,...

Rubrik recently announced a strategic collaboration agreement with Amazon Web Services to enhance cybersecurity and advance secure AI adoption for organizations operating in cloud environments. This partnership introduces Rubrik’s Preemptive Recovery Engine to AWS customers, enabling proactive cyber resilience and unified recovery solutions against sophisticated threats. We'll explore how Rubrik's integration of preemptive data recovery with AWS could strengthen its position in the rapidly...

Adobe (ADBE) shared fresh updates this week, highlighting a substantial jump in online consumer spending along with a growing preference for mobile-first shopping. The company also expanded its Adobe Express partnership into India, unlocking access to millions of new creators. See our latest analysis for Adobe. Adobe shares have been on a choppy ride lately, with enthusiasm around innovation and new international partnerships offset by some persistent concerns. The stock's total shareholder...

Global-E Online (GLBE) has caught investors’ attention recently as its stock shifted direction following a few weeks of ups and downs. The company’s performance raises interesting questions for those weighing its potential after past volatility. See our latest analysis for Global-E Online. After a bumpy ride in the first half of the year, Global-E Online's share price has rebounded with a 15.2% gain over the past 90 days, suggesting some renewed optimism despite a year-to-date share price...

Zenas BioPharma (ZBIO) is in the spotlight after announcing strong Phase 2 results for obexelimab in relapsing multiple sclerosis, the launch of key Phase 3 trials, and a major funding deal with Royalty Pharma. See our latest analysis for Zenas BioPharma. Zenas BioPharma's impressive 90-day share price return of 108.09% and an exceptional year-to-date gain of 288.46% point to surging investor optimism, propelled by breakthrough clinical results and major funding milestones. Short-term...

Banc of California (BANC) shares have edged higher lately, with the stock up about 12% year to date and returning roughly 10% over the past three months. Investors seem to be considering the company’s growth story as markets assess recent performance. See our latest analysis for Banc of California. Banc of California’s latest share price return of nearly 12% this year stands out, with the momentum picking up pace over the past quarter. The total shareholder return over the last twelve months...

Earlier this month, McEwen Inc. reported a consolidated third-quarter production of 29,662 gold equivalent ounces, down from last year, and issued revised 2025 production guidance of 112,000–123,000 GEOs, narrowing its prior range. Despite operational headwinds and lower production figures, McEwen's net loss significantly narrowed for both the quarter and nine-month periods, reflecting tighter cost controls and improved financial resilience. We'll now explore how McEwen's reduced production...

Wondering if First Solar’s recent performance means the stock is a bargain or just riding a wave? You’re in the right place for a closer look at what the numbers (and a bit of context) might really be telling us. First Solar’s stock has made some serious moves lately, climbing 35.7% year-to-date and 32.9% over the past year. However, it dipped 5.4% in the past week, which may signal that volatility could be as much an opportunity as a warning sign. This past month, First Solar’s price shifts...

California Water Service Group (CWT) recently drew attention after a Baird analyst updated their outlook. This update followed the release of the company’s third-quarter results and management’s comments on pending regulatory decisions and infrastructure plans. See our latest analysis for California Water Service Group. California Water Service Group’s share price has hovered near the flatline in recent months, but momentum has not yet shifted in a meaningful way. Over the past year, the...

In the past week, Bristol Myers Squibb and Johnson & Johnson announced the early discontinuation of their Phase 3 Librexia ACS trial for milvexian in acute coronary syndrome patients after an interim analysis indicated the trial would not achieve its primary efficacy goal, although no new safety issues were identified. This outcome has positioned increased attention on the success of Bristol Myers Squibb’s other late-stage cardiovascular programs and the company’s ability to manage pipeline...

The Cincinnati Bengals announced a partnership with Shift4 Payments to upgrade and streamline all payment transactions throughout Paycor Stadium, leveraging Shift4’s commerce platform for food and beverage concessions. This move highlights Shift4’s expanding presence in the sports and entertainment sector, aiming to deliver faster and more secure payment experiences for fans. We’ll explore how the Bengals partnership may influence Shift4’s broader investment narrative and potential sector...

Curious whether Bitmine Immersion Technologies is actually worth its eye-catching stock price? You're not alone, and there's a lot more to the value story than meets the eye. The stock has rocketed 473.3% over the past year, even after a recent dip of 36.1% in the last month. This shows just how quickly sentiment and growth expectations can shift. Bitmine Immersion Technologies has attracted attention amid recent industry chatter about high-performance computing demand and renewed discussion...

DorianG (LPG) just announced a $0.65 per share irregular cash dividend and revealed second quarter earnings that showed a sharp jump in both revenue and net income compared to last year. Investors are watching these moves closely. See our latest analysis for DorianG. DorianG’s jump in second quarter profits and generous cash dividend have certainly caught investors’ attention, but the share price hasn’t delivered the same fireworks. It is trading at $26.72 after a modest 1-day move, while its...

Crane NXT (CXT) delivered a clear signal to investors by raising its full-year 2025 sales growth guidance and posting increased third quarter sales and net income compared to last year. These updates highlight strengthening momentum for the company. See our latest analysis for Crane NXT. Following the upbeat sales outlook and higher earnings, Crane NXT’s share price has shown some volatility, down 13.3% over the last month. However, its total shareholder return over the past year remains...

Trevi Therapeutics (TRVI) reported third-quarter results that showed a smaller net loss and improved loss per share compared to last year. This is a sign of strengthening finances as the company advances its chronic cough program in idiopathic pulmonary fibrosis. See our latest analysis for Trevi Therapeutics. Investors have taken notice of Trevi Therapeutics’ streamlined losses and clinical progress, sending its share price up over 51% in the past three months and fueling a remarkable 160.8%...

Genworth Financial recently announced past third quarter results, reporting revenue of US$1,935 million and net income of US$116 million, both up from the previous year, along with updates on its share repurchase program totaling over 116 million shares bought since 2022. The combination of consistent earnings growth and a significant buyback program underscores the company's ongoing efforts to enhance shareholder value. We'll examine how Genworth Financial's continued earnings growth and...

Costco Wholesale (COST) caught investor attention this week as its stock moved slightly lower, closing at $922.98. While the shift is modest, some are watching for longer-term trends following mild recent declines. See our latest analysis for Costco Wholesale. Costco’s slight dip this week follows a broader trend of cooling momentum, as its 30-day share price return is down 3.35% and gains year-to-date are now just 1.45%. Still, the company’s long-term performance remains impressive, with a...

Rivian Automotive (RIVN) just shared two important updates for investors, announcing third quarter earnings along with a reaffirmed production outlook for 2025. The latest results highlight higher revenue and a smaller net loss. See our latest analysis for Rivian Automotive. Momentum has returned for Rivian’s shares, with a 23.45% 90-day share price return and the stock up 14.04% so far in 2025. The recent reaffirmed production guidance and revenue gains appear to have boosted confidence...

American Superconductor (AMSC) just announced its second quarter earnings, highlighting a clear jump in sales over last year. For the first half of the year, both net income and earnings per share saw substantial improvement. This gives investors more to consider for the months ahead. See our latest analysis for American Superconductor. American Superconductor’s upbeat earnings and guidance have come against the backdrop of a rollercoaster year for its share price. While the stock’s 12-month...